We are live on ! Find out more
John Overdeck

John Overdeck Two Sigma Investments

AUM $142B Turnover 29.79%
1-Year Est. Return 28.66%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+28.66%
3 Year Est. Return
+132.23%
5 Year Est. Return
+130.79%
10 Year Est. Return
+609.97%
AUM
$23.3B
AUM Growth
+$2.3B
Cap. Flow
+$1.28B
Cap. Flow %
5.5%
Top 10 Hldgs %
7.42%
Holding
3,523
New
779
Increased
1,113
Reduced
952
Closed
661
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$175M
2
KR icon
Kroger
KR
+$148M
3
ELV icon
Elevance Health
ELV
+$122M
4
EA icon
Electronic Arts
EA
+$120M
5
ABT icon
Abbott
ABT
+$119M

Top Sells

Rank Stock Value
1
TWC
Time Warner Cable
TWC
+$181M
2
HAL icon
Halliburton
HAL
+$152M
3
PFE icon
Pfizer
PFE
+$145M
4
AGN
Allergan plc
AGN
+$124M
5
AZO icon
AutoZone
AZO
+$113M

Sector Composition

Rank Sector Weight
1 Healthcare 13.33%
2 Technology 13.06%
3 Miscellaneous 12.62%
4 Consumer Discretionary 10.5%
5 Financials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KO icon
101
Coca-Cola
KO
$421B
$51.2M 0.22%
1,128,390
+1,065,410
+1,692% +$48.1M
2016 Q1
1 quarter
MA icon
102
Mastercard
MA
$552B
$51.1M 0.22%
580,260
+242,692
+72% +$23.2M
2016 Q1
1 quarter
PFE icon
103
PUT
Pfizer
PFE
$157B
$51M 0.22%
1,525,560
+1,078,348
+241% +$34.4M
2015 Q1
5 quarters
IDXX icon
104
Idexx Laboratories
IDXX
$54B
$50.5M 0.22%
543,983
+154,955
+40% +$13.3M
2016 Q1
1 quarter
XOM icon
105
PUT
ExxonMobil
XOM
$657B
$48.4M 0.21%
516,500
+239,500
+86% +$21.2M
2015 Q1
5 quarters
CPGX
106
DELISTED
Columbia Pipeline Group
CPGX
$48.3M 0.21%
1,893,804
+1,754,564
+1,260% +$44.7M
2015 Q3
3 quarters
TTWO icon
107
Take-Two Interactive
TTWO
$39.5B
$48.3M 0.21%
1,272,704
+450,752
+55% +$16.6M
2015 Q1
5 quarters
JBLU icon
108
JetBlue
JBLU
$1.27B
$47.9M 0.21%
2,890,566
+2,340,312
+425% +$43.5M
2015 Q2
4 quarters
PFE icon
109
Pfizer
PFE
$157B
$47.3M 0.2%
1,415,383
-4,552,699
-76% -$145M
2015 Q2
4 quarters
CCL icon
110
Carnival
CCL
$36.5B
$47.2M 0.2%
1,068,574
+1,037,370
+3,324% +$50.9M
2013 Q2
12 quarters
AME icon
111
Ametek
AME
$51.3B
$47.1M 0.2%
1,019,006
+395,689
+63% +$19M
2016 Q1
1 quarter
PFE icon
112
CALL
Pfizer
PFE
$157B
$47M 0.2%
1,405,825
+1,033,763
+278% +$33M
2015 Q1
5 quarters
A icon
113
Agilent Technologies
A
$48.1B
$46.9M 0.2%
1,057,350
+324,231
+44% +$14M
2013 Q2
12 quarters
WDAY icon
114
Workday
WDAY
$43.2B
$46.9M 0.2%
627,670
+349,162
+125% +$26.6M
2015 Q4
2 quarters
LUV icon
115
Southwest Airlines
LUV
$22B
$46.8M 0.2%
1,192,374
-34,140
-3% -$1.46M
2013 Q4
10 quarters
COP icon
116
ConocoPhillips
COP
$162B
$46.5M 0.2%
+1,065,834
New +$47M
2016 Q2
0 quarters
DNKN
117
DELISTED
Dunkin' Brands Group
DNKN
$46.2M 0.2%
1,058,875
+754,755
+248% +$34.5M
2015 Q3
3 quarters
DOC icon
118
Healthpeak Properties
DOC
$13.5B
$45.7M 0.2%
+1,418,103
New +$44M
2016 Q2
0 quarters
STLD icon
119
Steel Dynamics
STLD
$29.8B
$45.5M 0.2%
1,857,007
+740,831
+66% +$18.1M
2014 Q1
9 quarters
IRM icon
120
Iron Mountain
IRM
$31.2B
$45.3M 0.19%
1,138,273
+1,020,914
+870% +$37.2M
2015 Q4
2 quarters
VEEV icon
121
Veeva Systems
VEEV
$43.2B
$44.8M 0.19%
+1,313,053
New +$39M
2016 Q2
0 quarters
EL icon
122
Estee Lauder
EL
$36.5B
$43.9M 0.19%
482,429
+311,155
+182% +$29M
2016 Q1
1 quarter
HLF icon
123
Herbalife
HLF
$1.6B
$43.3M 0.19%
1,479,986
-164,552
-10% -$4.93M
2016 Q1
1 quarter
IHS icon
124
DELISTED
IHS Inc
IHS
$42.6M 0.18%
368,251
+146,704
+66% +$17.6M
2016 Q1
1 quarter
MAS icon
125
Masco
MAS
$16.1B
$42.5M 0.18%
1,374,887
-819,235
-37% -$25.8M
2013 Q3
11 quarters

Similar funds

John Overdeck's Q2 2016 Portfolio in Review

As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

John Overdeck deployed $1.28B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Miscellaneous.

On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.

  • John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
  • John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
  • John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
  • John Overdeck fully exited Time Warner Cable in Q2 2016, selling an estimated $181M.
  • John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
  • John Overdeck opened 779 new positions and closed 661 in Q2 2016.
  • John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.

Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.